Cover Image
Market Research Report

Vitamin China E-News 1808

Published by CCM Data & Business Intelligence Product code 607204
Published Content info 22 Pages
Delivery time: 1-2 business days
Price
Back to Top
Vitamin China E-News 1808
Published: August 30, 2018 Content info: 22 Pages
Description

Welcome to the August Issue of Vitamins China E-News.

This newsletter will help you stay ahead of the game in this fast-changing market with real-time reporting on the entire vitamin industry chain, from raw materials to end consumption. It includes breaking news from China and abroad, the latest market data (price, import & export, production, consumption, operating rates, etc.), in-depth analysis of market trends, and expert commentary from industry insiders.

Here is the Editor's Note for you to know about the August issue specifically:

The vitamin market was supported by several facts, including the strict environmental policies, the production suspension for equipment overhauls and maintenance, and the production accidents in certain producers. However, the increases in prices witnessed in July did not continue this month as users tended to consume their inventories, being careful in buying new ones.

There was a piece of good news for the VK3 market, which has been weak since this March. A production accident occurred in Hubei Zhenhua, a leading producer of sodium dichromate and VK3 in China. It is likely to start equipment overhauls and maintenance, which will negatively impact the supply of the raw material and product to some extent.

VA prices rebounded in early period of this month as a result of another accident in a producer named Shangyu NHU. However, the effect did not last long and VA prices became low again in the last twenty days with the recovery of the supply by BASF.

Shandong and Jiangsu provinces have unveiled stricter policies regarding the rectification of chemical parks. In seven cities of Shandong, new chemical parks are prohibited from being built; the coastal chemical parks in Jiangsu have to meet all the requirements given by the authorities or they will be urged to be closed. Given the fact that some producers of vitamins and raw materials are located in one of these parks, the price of relevant vitamins may be supported.

Some new capacities will be added in the domestic vitamin market. Shandong Hwatsonhas obtained the license to produce feed-grade D-calcium pantothenate; Garden Biochemical has planned to build production lines for feed-grade VD3, premium VD3, and the key intermediate in the production of VD3; Hebei Sancess has seen its business extend into vitamin APIs, with the VB5 and VB6 projects being advanced further.

Vitamins China E-News is a monthly published newsletter, which can be downloaded in PDF format. The subscription mode for this newsletter is yearly and the subscriber will receive 12 issues per year.

Table of Contents

Table of Contents

  • Headline
  • Editor's Note
  • Column 1 Governmental Direction
  • Measures for rectification of chemical parks in Shandong and Jiangsu provinces
  • Column 2 Market Dynamics
  • Shijiazhuang local government makes policies to develop big health industry
  • Column 3 Company Developments
  • Garden Biochemical discloses construction plans for several projects
  • Update on Guangji Pharmaceutical's VB2 export to EU
  • Tangshan No.1 Pharmaceutical's VB5 and VB6 project enters construction phase
  • BY-HEALTH sees good financial results in H1 2018
  • Guangji Pharmaceutical to develop in in Optical Valley Bio-pharmaceutical Industrial Park
  • Zhejiang Shengda receives falling revenue from biotin and folic acid sales
  • Column 4 Import and Export Analysis
  • Zhejiang Medicine exempted from additional tariffs in US
  • Column 5 Price Update
  • Ex-works prices of selected vitamins in China, Aug. 2018
  • VK3 prices supported by accident in producer Hubei Zhenhua
  • Column 6 News in Brief
  • Accident occurs at Shangyu NHU
  • Officials of five districts/counties in Beijing-Tianjin-Hebei region and nearby areas interviewed
  • Qingdao Hualilang raises folic acid quotations
  • Brother Enterprises see change in category of industry
  • Garden Biochemical has right to use two pieces of land
  • Weixinkang Medicine's Injectable Pediatric Multivitamins registration application approved
  • Huisheng Pharmaceutical postpones production resumption for high temperature
  • Shandong Hwatson obtains VB5 feed additive production license
  • DSM discloses patent suit against Anhui Tiger in China for patent infringement
  • BASF reduces production at its Ludwigshafen site due to low water level in Rhine
Back to Top